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Background: Idiopathic interstitial pneumonia (IIP) is characterized by chronic interstitial
inflammation and fibrosis. Although mounting evidence has suggested that toll-like receptor
(TLR) 2 and TLR4 are involved in the pathogenesis of non-infectious lung injury in vitro and
in mouse models, their roles in human IIP remain unknown.
Methods: To address this issue, we investigated the expression patterns of TLR2 and TLR4 by
immunohistochemistry in resected lung tissues from patients with usual interstitial pneumonia
(UIP) or nonspecific interstitial pneumonia (NSIP).
Results: Type II pneumocytes, bronchial epithelial cells (BECs), and alveolar macrophages ac-
counted for the majority of TLR2- and TLR4-expressing cells in both UIP and NSIP. The numbers
of TLR2 and TLR4-positive respiratory epithelial (RE) cells, including type II pneumocytes and
BECs, were significantly greater in UIP and NSIP than in the control. In particular, the numbers
of TLR2-positive RE cells were much greater in UIP than in NSIP. The intensities of TLR2 andof Pathology and Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro,
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784 H. Go et al.TLR4 expression in type II pneumocytes were also significantly stronger in UIP and NSIP than in
the control. A comparison of the TLR expression patterns between the fibroblastic and fibrotic
areas in UIP indicated that the numbers TLR2 and TLR4-positive RE cells were similar in fibro-
blastic areas, whereas the TLR2-positive RE cells outnumbered the TLR4-positive RE cells in
the fibrotic areas.
Conclusions: This study demonstrates that RE cells over-express TLR2 and TLR4 in the lungs of
IIP patients. These findings suggest that high expression of TLRs may contribute to the patho-
genesis of human IIP.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Chronic diffuse or interstitial lung disease (ILD) includes a
spectrum of non-infectious inflammatory conditions that
typically evolves over weeks, months, or years [1]. Idio-
pathic interstitial pneumonia (IIP) is a subtype of ILD
characterized by interstitial inflammation and a variable
degree of fibrosis. Usual interstitial pneumonia (UIP) and
nonspecific interstitial pneumonia (NSIP) are the major
histologic patterns in human IIP. The most unique and
diagnostic characteristics of UIP are heterogeneous ap-
pearances at a low magnification. Thus, areas of fibrosis
with scarring and honeycomb changes are interspersed with
areas of less-affected or nearly normal parenchyma [2]. In
addition to the advanced fibrotic areas, scattered fibro-
blastic foci of proliferating fibroblasts or myofibroblasts are
observed in UIP. In contrast, NSIP is characterized by the
spatially and temporally homogeneous involvement of the
pulmonary parenchyma with inflammatory cell infiltration
and/or fibrosis in the interstitium [3]. In general, UIP is
associated with the idiopathic pulmonary fibrosis (IPF) that
is characterized by the worst prognosis, including the pro-
gressive destruction of the lung and the decline of pulmo-
nary function [4]. Several hypotheses have been suggested
to explain the mechanisms of pulmonary fibrosis, for
example, the loss of integrity of the alveolar-capillary
barrier basement membrane; cytokines, such as TGF-b;
continuous stimulus of antigen; epithelial-to-mesenchymal
transition; and recruitment of bone marrow-derived fibro-
genic progenitor cells [5]. However, the pathogenesis of
human IPF remains unknown.
Toll-like receptors (TLRs) are a family of pattern-
recognition receptors that trigger innate immune re-
sponses that are involved in the first line of host defense
against microbial infection. These receptors also modulate
adaptive immune responses. In addition to sensing the
pathogen-associated molecular patterns (PAMP), TLRs also
recognize various host-derived endogenous ligands [i.e.,
damage-associated molecular patterns (DAMP)] associated
with tissue injury. TLRs are, thus, involved in the regulation
of inflammatory or reparative processes and the remodeling
of tissue during non-infectious tissue injury. TLRs are
expressed in non-hematopoietic cells, including endothelial
and epithelial cells, as well as immune cells [6]. Their
expression patterns and functions vary as a function of the
cell types, tissues, and forms of infectious or non-infectious
stimuli [7,8]. Among TLRs, TLR2 and TLR4 have been
demonstrated to play crucial roles in regulating non-
infectious lung injury, although the results have beeninconsistent [7e12]. TLR2 and TLR4 on alveolar macro-
phage and lung epithelial cells recognize hyaluronan, an
extracellular matrix degradation product generated during
lung tissue injury. A study using both TLR2- and TLR4-
deficient mice suggested that these receptors promote in-
flammatory response and recovery from acute lung injury
[7,12]. TLR4 was reported by others to promote the reso-
lution of inflammation and fibrosis after acute or chronic
lung injury [10]. In contrast to TLR4, blocking TLR2 atten-
uated bleomycin-induced pulmonary fibrosis, which sug-
gested that TLR2-mediated signals contributed to
pulmonary fibrosis [11]. Moreover, we recently demon-
strated that TLR2, expressed by respiratory epithelial (RE)
cells rather than immune cells, promoted bleomycin-
induced pulmonary fibrosis (BIPF) by increasing the pro-
ducing IL-27 and chemokines by these cells [9]. These
findings suggest that TLRs expressed on RE cells may play a
crucial role in the regulation of human IIP. Therefore, a
comprehensive investigation of the expression patterns of
TLRs in the lung tissues from IIP patients should be helpful
for understanding the TLR-mediated regulation of IIP. The
cellular expression of TLRs in chronic human IIP has not
previously been described, although studies using cell lines,
bronchoalveolar lavage (BAL) fluid, or animal tissues have
been reported. TLR2 expression was elevated in BAL fluid
from IPF patients compared to control [13]. However, there
have been no reports of the TLR expression patterns in in-
dividual cell types in lung tissues from patients with IPF.
Therefore, we investigated the expression patterns of TLR2
and TLR4 using surgically resected lung tissues from UIP or
NSIP patients in comparison with control tissues.Materials and methods
Patient selection
We selected 65 patients who underwent lung wedge re-
sections under the clinical and radiological suspicion of IPF
or NSIP at Seoul National University Hospital between 2005
and 2011. Among them, 36 cases were histologically
confirmed to be UIP, and 29 cases were diagnosed as NSIP
based on the diagnostic guidelines [1,3,14]. In addition,
normal or mildly inflamed lung parenchyma was obtained
from 18 patients who underwent lobectomy for primary
pulmonary adenocarcinomas, and control tissues were
taken from regions at least 5 cm away from the tumors. The
clinical data were obtained from the medical record, and
are summarized in Table 1. This study followed the World
Table 1 Clinical features of the study subjects.
Control NSIP UIP
No. of patients 18 29 36
Age, years
(mean  S.D.)
65.6  9.3 54.6  11.5 61.2  12.3
Sex, M/F 9/9 8/21 18/18
PCO2 (mean  S.D.) 40.7  4.1 46.0  7.0 40.2  8.0
pO2 (mean  S.D.) 122.3  44.7 104.6  38.1 113.5  50.2
FEV1 (mean  S.D.) 2.3  0.6 1.9  0.8 2.0  0.7
%VC (mean  S.D.) 71.4  8.7 84.4  6.6 79.5  10.4
FEF25-75
(mean  S.D.)
1.8  0.8 2.4  1.1 2.3  1.0
%DLCO
(mean  S.D.)
100.2  19.4 53.6  19.1 61.1  22.2
NSIP, Nonspecific interstitial pneumonia; UIP, usual interstitial
pneumonia; FEV1, forced expiratory volume in 1 s; VC, vital
capacity; FEF25-75, forced expiratory flow from 25 to 75% of the
vital capacity; DLCO, carbon monoxide diffusion in the lung;
S.D., standard deviation.
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approved by the institutional review board of Seoul Na-
tional University Hospital (IRB No.: H-1104-061-358).
Histologic examination and immunohistochemistry
Formalin-fixed and paraffin-embedded (FFPE) tissue blocks
were used for histological and immunohistochemical ex-
aminations. Serial 4 mm-thick sections were cut from each
block and processed for hematoxylin & eosin (H&E) staining
and immunohistochemistry. Two pathologists (HG and DHC)
reviewed the H&E and immunostained slides of all cases
independently or together for consensus.
For immunohistochemistry, sections were deparaffinized
with xylene for 20 min, rehydrated with serially diluted
ethanol, and immunostained using antibodies against TLR2
(1:500, rabbit polyclonal, Cat No. PAB11280, Abnova, Taipei
city, Taiwan) and TLR4 (1:1000, rabbit polyclonal, Cat No.
PAB15432, Abnova) as primary antibodies. Detection was
performed using an Envision kit (Dako, Ely, U.K.) containing
a peroxidase-conjugated anti-mouse Ig polymer. The sec-
tions were then incubated with diaminobenzidine for 5 min
to visualize the reaction.
For the quantitative analysis of the immunohistochem-
ical results, the immunostained slides were scanned using
the AperioScanscope Cs (Aperio Technologies, Vista, CA)
with a 20  objective. Using virtual microscope software
(ImageScope V12.0.0.5039, Aperio Technologies), 10 fields
(total area; 966,042 mm2) were randomly selected and
captured in each case. The numbers of TLR2- and TLR4-
positive cells, types of TLR2- and TLR4-expressing cells,
and intensity of immunostaining were independently eval-
uated by two pathologists (HG and JK). The identification of
BECs, type II or type I pneumocytes was performed on a
morphological basis [1,15]. The mean numbers and stan-
dard deviations (S.D.) of TLR2- and TLR4-positive cells were
calculated from values from 10 fields. The intensity of the
TLR2 and TLR4 expression was scored from absent (0) to
strong (3þ).Statistical analysis
To compare the numbers of TLR2- and TLR4-positive cells
and the intensity of TLR2 and TLR4 expression between
these groups, the KruskaleWallis test was used. Statistical
significance was defined as a value of p < 0.05. Post-hoc
comparisons were performed by using Bonferroni-
corrected ManneWhitney U tests; in this case, a p-value
of <0.017 was considered statistically significant. Paired
Student’s t-test was performed to compare the number of
TLR2- and TLR4-positive cells between the fibroblastic and
fibrotic areas in each case. All statistical tests were two-
sided. The statistical analyses were conducted using the
IBM-SPSS Statistics software package (version 19.0; IBM
Corporation, Armonk, NY, U.S.A.).
Results
Expression patterns of TLR2 and TLR4 in human
lung tissues
In the control tissues, TLR2 expression was observed in RE
cells, alveolar macrophages, and immune cells, including
lymphocytes and neutrophils. Among the RE cells, TLR2 was
expressed in the cytoplasm of bronchial epithelial cells
(BECs) and type II pneumocytes (Fig. 1A and C). In contrast,
TLR2 expression was not observed in peribronchial muscles,
fibroblasts, endothelial cells, or type I pneumocytes. Like
TLR2, TLR4 was also expressed in BECs, type II pneumo-
cytes, alveolar macrophages, and immune cells (Fig. 1B and
D). Of note, the staining intensity of TLR4 in the type II
pneumocytes was variable. Specifically, TLR4 expression in
the type II pneumocyte was generally weak, but increased
in some cases where inflammatory cell infiltration was
prominent (Fig. 1E).
In chronic IIP, i.e., UIP and NSIP, the types of TLR2- and
TLR4-expressing cells were basically similar to those of the
control tissues. BECs, Type II pneumocytes, and alveolar
macrophages comprised the majority of TLR2- and TLR4-
expressing cells in chronic IIP. However, the frequencies
and intensities of TLR2 and TLR4 expression in these cells of
chronic IIP tissues were different from the control tissues
(Figs. 2 and 3AeF). Metaplastic ciliated columnar epithelial
cells, considered to have originated from BEC and found in
chronic IIP, also expressed TLR2 and TLR4, whereas the
hyperplastic peribronchial muscular tissues and endothelial
cells did not. A few fibroblasts or myofibroblasts in the
fibroblastic foci and fibrotic scar areas of the tissues from
chronic IIP patients expressed TLR2 (Fig. 3C and D), but not
TLR4 (Fig. 3E and F).
The relationship between TLR2 and TLR4 expressions in
chronic IIP was different according to the pathologic pat-
terns. In NSIP patients, the numbers of TLR2-expressing
epithelial cells were positively correlated with those of
TLR4-expressing epithelial cells as follows: for type II
pneumocyte with Spearman’s correlation coefficient (r) of
0.657 (p < 0.001); for BEC with r of 0.392 (p Z 0.036); for
RE cells with r of 0.471 (p Z 0.010). On the other hand, in
UIP cases, the numbers of TLR2-positive type II pneumo-
cytes and RE cells showed no relationship with those of
TLR4-positive type II pneumocytes and RE cells [r Z 0.276
Figure 1 Expression of TLR2 and TLR4 in control lung tissues. TLR2 (A and C) and TLR4 (B and D) are expressed in bronchial
epithelial cells (“BEC”), type II pneumocytes (“P”), and alveolar macrophages (“M”). (E) TLR4 expression is increased in type II
pneumocytes in a case showing inflammatory cell infiltration. (A and B,  40 and CeE,  200).
786 H. Go et al.(p Z 0.104) and r Z 0.282 (p Z 0.096), respectively],
although the numbers of TLR2-positive BECs were positively
correlated with those of TLR4-positive BECs (rZ 0.346 and
p Z 0.039).
Different expression patterns of TLR2 in
respiratory epithelial cells of human chronic IIP
Although immune cells other than alveolar macrophages
also expressed TLR2 and TLR4 in chronic IIP, the degree of
immune cell infiltration in chronic IIP was variable. More-
over, the expression intensity of TLR2 and TLR4 in the im-
mune cells, including alveolar macrophages of the IIP
tissues, was similar to that of the control tissues. These
results led us to compare the TLR2 and TLR4 expression in
RE cells in the control, NSIP, and UIP lung tissues.
The numbers and expression intensities of TLR2-positive
RE cells are displayed in Fig. 4AeC and summarized in Table2. In addition to the epithelial cells lining the bronchus or
bronchioles, metaplastic columnar ciliated epithelial cells
in honeycomb areas were also included in BECs. The mean
numbers of TLR2-expressing RE cells, i.e., type II pneu-
mocyte plus BEC, were significantly higher in chronic IIP
than in the control tissues (NSIP vs. control, p < 0.001; UIP
vs. control, p < 0.001). Furthermore, the numbers of TLR2-
expressing RE cells were significantly higher in UIP than
NSIP (p < 0.001) (Fig. 4A and Table 2). The analysis of the
numbers of TLR2-positive RE cells showed that the numbers
of TLR2-positive type II pneumocytes were significantly
higher in either NSIP or UIP compared to control (p < 0.001,
both). The numbers of TLR2-expressing type II pneumocytes
were slightly higher in the UIP tissues than in those from the
NSIP patients, but the difference was not statistically sig-
nificant. On the other hand, the numbers of TLR2-positive
BEC were significantly higher in UIP than in NSIP
(p < 0.001) or control (p < 0.001) (Fig. 4B and Table 2). In
Figure 2 Expression of TLR2 and TLR4 in nonspecific interstitial pneumonia.TLR2 (A and C) and TLR4 (B and D) were over-
expressed in respiratory epithelial cells in nonspecific interstitial pneumonia (NSIP), cellular type. TLR2 (E) and TLR4 (F) were
also over-expressed by respiratory epithelial cells in NSIP, fibrosing type. (A and B,  40 and CeF  200. “P”, type II pneumocyte;
“M”, alveolar macrophage).
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cells was moderate (Figs. 1C, 2C and 2E, 3C and 3D). The
intensity of TLR2 expression in type II pneumocytes was not
different between NSIP and UIP (Fig. 4C and Table 2).
Furthermore, the intensity of TLR2 expression in BECs and
alveolar macrophages was similar between control, NSIP,
and UIP cases. However, the intensity the TLR2 staining of
type II pneumocytes was much stronger in NSIP or UIP than
that in control (p < 0.001, both).
Different expression patterns of TLR4 in
respiratory epithelial cells of human chronic IIP
The numbers and the expression intensity of TLR4-positive
RE cells are displayed in Fig. 4DeF and summarized in Table
3. The mean numbers of TLR4-expressing RE cells, i.e., type
II pneumocyte plus BECs, were significantly higher inchronic IIP than in control (NSIP vs. control, p < 0.001; NSIP
vs. control, p < 0.001). However, the numbers of TLR4-
positive RE cells were not significantly greater in UIP than
NSIP, which contrasted with the frequent TLR2 expression
in RE cells of UIP compared to NSIP (Fig. 4D and Table 3). In
terms of RE cell types, the numbers of either TLR4-positive
type II pneumocytes or BECs were significantly higher in the
NSIP and UIP tissues than in the control (p < 0.001). In
contrast, the numbers of TLR4-expressing type II pneumo-
cytes were approximately the same for the UIP and NSIP
samples, similar to the results for TLR2. The numbers of
TLR4-positive BEC were greater in the UIP than on the NSIP
tissues (pZ 0.003) (Fig. 4E and Table 3). Most of the type II
pneumocytes in the chronic IIP tissues showed moderate
intensity of TLR4 expression, which was much stronger than
that of the control tissues (NSIP vs. control, p < 0.001; UIP
vs. control, p < 0.001) (Figs. 1D, E, 2D, 2F, 3E and 3F).
Figure 3 Expression of TLR2 and TLR4 in usual interstitial pneumonia.TLR2 (A) and TLR4 (B) were over-expressed in respiratory
epithelial cells in usual interstitial pneumonia (UIP). TLR2 expression was increased in a fibrotic area of UIP (C) compared to a
fibroblastic area (D) in a representative case. TLR4 expression was down-regulated in the fibrotic areas (E) relative to fibroblastic
areas (F) in a case of UIP. (A and B,  40 and CeF,  200. “BEC”, bronchial epithelial cell; “P”, type II pneumocyte; “M”, alveolar
macrophage).
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type II pneumocytes between NSIP and UIP (Fig. 4F and
Table 3). Similar to the expression patterns of TLR4 in
control tissues, BECs expressed TLR4 at variable intensities
from negative to strong, even within a single category of
disease. Thus, no significant difference was observed for
TLR4 expression intensity between control and chronic IIP.
The expression intensity of TLR4 in alveolar macrophages
was generally weak and comparable in control, NSIP, and
UIP cases.
Differences in TLR2 and TLR4 expression patterns
between the fibroblastic and fibrotic areas in
human UIP
Whereas interstitial inflammation and/or fibrosis were
temporally and spatially uniform in NSIP, temporallyheterogeneous fibrosis due to tissue injury is typically
progressive and irreversible in UIP. In the resected lung
tissues of UIP cases, fibroblastic areas composed of prolif-
erating fibroblasts or myofibroblasts and advanced fibrotic
areas are frequently found, suggesting that fibrosis is
actively ongoing and progressive in the lung of UIP patients.
Higher numbers of TLR2-positive RE cells, but not TLR4-
positive cells, in UIP compared to NSIP led us to hypothesize
that TLR2 might contribute more than TLR4 to fibrosis in
human chronic IIP. To provide more evidence for this, we
compared the TLR2 and TLR4 expression between the
fibroblastic and fibrotic areas in UIP. Fig. 3 shows repre-
sentative images demonstrating that the RE cells in the
honeycomb areas of UIP frequently showed increased TLR2
expression compared to fibroblastic areas (Fig. 3C and D).
On the other hand, TLR4 expression in the RE cells in the
fibrotic areas was weaker, and the majority of metaplastic
Figure 4 Numbers of TLR2- and TLR4-expressing respiratory epithelial cells and their expression intensity in human chronic
idiopathic interstitial pneumonia. (A) The numbers of TLR2-positive respiratory epithelial cells, including type II pneumocytes and
bronchial epithelial cells (BECs), were much higher in nonspecific interstitial pneumonia (NSIP) and usual interstitial pneumonia
(UIP) compared to control. (B) The numbers of TLR2-positive type II pneumocytes or BECs are displayed in control, NSIP, and UIP.
(C) The intensity of TLR2 expression in type II pneumocytes was stronger in NSIP and UIP than control. (D) The numbers of TLR4-
positive respiratory epithelial cells including type II pneumocytes plus BECs were increased in NSIP and UIP than control. (E) The
numbers of TLR4-positive type II pneumocytes or BECs are shown. (F) The intensity of TLR4 expression in type II pneumocytes was
stronger in NSIP and UIP than control.
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TLR4 (Fig. 3). Quantitatively, the mean numbers of type II
pneumocytes and BECs expressing TLR2 or TLR4 were
similar in the fibroblastic areas; however, TLR2-positive
type II pneumocytes and BECs far outnumbered the TLR4-
positive cells in the fibrotic areas (Table 4). Overall, the
mean numbers of TLR2-positive type II pneumocytes or
BECs were significantly higher in fibrotic areas compared to
the fibroblastic areas, whereas the numbers of TLR4-
positive cells were similar between these two areas
(Fig. 5A and B). Moreover, the numbers of TLR2-expressing
RE cells were markedly greater in the fibrotic areas rather
than in fibroblastic areas of each case (p < 0.001 by paired
Student’s t-test), while the differences in the numbers of
TLR4-expressing RE cells were only marginally significant
between two areas (Fig. 5C and D, Supplement figs1).Discussion
The present study demonstrated that TLR2 and TLR4 are
expressed in BECs, type II pneumocytes, alveolar macro-
phages, and immune cells in the control lung tissues.
Importantly, TLR2 and TLR4 expression in RE cells, including
BECs and type II pneumocytes, was increased in human IIP.
These findings suggest that the regulation of TLR2 and -4expression in the lung tissues might be involved in the
pathogenesis of chronic IIP in humans. Human RE cells,
including BECs and type II alveolar epithelial cells or
pneumocytes, have consistently been shown to express a
variety of TLRs and their signaling molecules, which elicit
different responses to microbial and/or endogenous ligands
[16e20]. However, the possible roles of TLR expression or
function in the context of human chronic IIP are not yet
well understood. Pneumocyte hyperplasia is invariably
prominent in almost all chronic IIP cases, and it has previ-
ously been suggested that proliferation of type II pneumo-
cytes might reflect alveolar damage [21,22]. Most type II
pneumocytes and BECs expressed TLR2 and TLR4 in human
normal and chronic IIP lung tissues, and TLR2 expression
was more polarized on the apical surface of BECs (Fig. 1C),
consistent with a previous report [19]. The numbers and
expression intensity of TLR2 or TLR4-expressing RE cells
were much higher in UIP and NSIP than control. In partic-
ular, the numbers of TLR2-positive RE cells were signifi-
cantly higher in UIP compared to NSIP; however, this was
not the case for TLR4. Furthermore, TLR2 expression was
maintained or significantly increased in type II pneumo-
cytes and metaplastic BECs in the fibrotic areas of UIP
compared with fibroblastic areas, whereas the TLR4
expression was similar between these two areas. In addi-
tion, a few fibroblasts/myofibroblasts in UIP tissues
Table 2 Toll-like receptor 2 (TLR2) expression in respiratory epithelial cells.
Control NSIP UIP p-Value
Mean (S.D.) Mean (S.D.) Mean (S.D.) Control vs. NSIP Control vs. UIP NSIP vs. UIP
Average number of TLR-2 positive RE cells (x 200)
Type II pneumo. 16.49 (9.60) 53.24 (18.45) 64.80 (20.74) <0.001* <0.001* 0.042
BEC 16.70 (5.76) 28.67 (22.74) 50.67 (27.75) 0.128 <0.001* <0.001*
Type II pneumo. þ BEC 33.19 (11.40) 81.92 (31.44) 115.47 (36.14) <0.001* <0.001* <0.001*
Intensity of TLR2-positive RE cells
Type II pneumo. 1.19 (0.55) 2.00 (0.40) 1.96 (0.53) <0.001* <0.001* 0.824
BEC 2.00 (0.00) 1.77 (0.43) 1.92 (0.37) 0.040 0.341 0.053
NSIP, nonspecific interstitial pneumonia; UIP, usual interstitial pneumonia; RE, respiratory epithelial; pneumo., pneumocyte; BEC,
bronchial epithelial cells; S.D., standard deviation. *p < 0.017 is considered statistically significant.
Table 3 Toll-like receptor 4 (TLR4) expression in respiratory epithelial cells.
Control NSIP UIP p-Value
Mean (S.D.) Mean (S.D.) Mean (S.D.) Control vs. NSIP Control vs. UIP NSIP vs. UIP
Average number TLR4-postiveRE cells (  200)
Type II pneumo. 19.21 (8.97) 60.78 (29.38) 60.43 (21.49) <0.001* <0.001* 0.792
BEC 11.31 (7.67) 25.35 (18.55) 38.68 (20.62) 0.001* <0.001* 0.003*
Type II pneumo. þ BEC 30.52 (3.74) 86.14 (42.42) 99.10 (28.91) <0.001* <0.001* 0.029
Intensity of TLR4-positive RE cells
Type II pneumo. 1.42 (0.40) 2.02 (0.45) 2.00 (0.40) <0.001* <0.001* 0.721
BEC 0.80 (0.77) 0.67 (0.62) 0.41 (0.56) 0.633 0.084 0.095
NSIP, nonspecific interstitial pneumonia; UIP, usual interstitial pneumonia; pneumo., pneumocyte; BEC, bronchial epithelial cells; S.D.,
standard deviation, *p < 0.017 is considered statistically significant.
790 H. Go et al.expressed TLR2 but not TLR4. It is possible that the TLR2-
positive fibroblastic cells in the fibroblastic foci of UIP
might have been derived from epithelial cells by epi-
thelialemesenchymal transition [23]. Collectively, our
findings indicate that TLR2 expression was much higher in
UIP than NISP, particularly in advanced fibrotic areas.
Consistent with our results, a study using BAL fluid immune
cells showed that TLR2, but not TLR4, expression was also
higher in IPF patients compared to control [13]. Thus, the
results suggest that TLR2 expression may be up-regulated in
RE cells and may contribute to progressive fibrosis of the
lungs. In agreement with the expression patterns of TLR2
and TLR4 in the lungs, several studies showed that the TLR2
and TLR4 on human BECs and type II pneumocytes are
functional, as indicated by activation of signaling pathway
and production of cytokines and chemokines upon stimu-
lation with their ligands [16,18,19]. Furthermore, TLR2
promoted bleomycin-induced immune responses andTable 4 Numbers of TLR2 and TLR4-expressing respiratory epit
Type II pneumo.
TLR2 TLR4
Areas Mean (S.D.) Mean (S.D.) p
Fibroblastic 61.69 (22.88) 62.67 (24.22) 0.8
Fibrotic 78.90 (41.19) 57.48 (29.84) 0.0
Pneumo., pneumocyte; BEC, bronchial epithelial cells; S.D., standardpulmonary fibrosis, whereas TLR4 signaling attenuated
pulmonary immune responses and fibrosis after lung injury
[11,24]. Previously, we reported a role for a TLR2-mediated
immune mechanism in BIPF by demonstrating that TLR2
signaling in RE cells promoted BIPF by inducing IL-27 and
chemokine production in mice. [9] Taken together, these
results suggest that TLR2 rather than TLR4 may promote
chronic IIP in humans as well as in animal pulmonary fibrosis
models. This hypothesis is further supported by previous
observations by ourselves and others that TLR2 signaling by
RE cells promotes BIPF, and the inhibition of TLR2 pathways
relieves pulmonary inflammation and fibrosis in the mouse
model [9,11].
Taken together, our findings suggested that TLR2 and
TLR4 expressed in RE cells may be involved in the path-
ogenesis of human chronic IIP and that TLR2, but nor
TLR4, on RE cells may contribute to pulmonary fibrosis in
human IPF.helial cells in the fibroblastic and fibrotic areas of UIP.
BEC
TLR2 TLR4
Mean (S.D.) Mean (S.D.) p
6 36.88 (25.41) 33.06 (24.75) 0.67
16* 95.28 (61.28) 58.09 (63.05) 0.025*
deviation, *P < 0.05 is considered statistically significant.
Figure 5 TLR2 and TLR4 expression patterns in respiratory epithelial cells in the fibroblastic and fibrotic areas of UIP. The mean
numbers of TLR2- (A) or TLR4- (B) expressing type II pneumocytes and bronchial epithelial cells (BECs) are compared in the
fibroblastic and fibrotic areas of usual interstitial pneumonia (UIP). The changes in the number of TLR2- (C) or TLR4- (D) positive
respiratory epithelial cells between the fibroblastic and fibrotic areas in UIP cases are illustrated.
TLR2 and 4 in chronic idiopathic interstitial pneumonia 791TLR4 recognizes hyaluronan fragments or diesel exhaust
and stimulates lung inflammation [12,24,25]. The TLR4-
MyD88-NF-KappaB-dependent pathway links signals to link
proinflammatory and pro-fibrotic signals in hepatic fibrosis
[26]. Lipopolysaccharide (LPS), a gram-negative bacterial
ligand, induced pulmonary fibrosis via TLR4-mediated
pathways [27,28]. In contrast, TLR4 was required for the
reduction of inflammation and fibrosis after acute and
chronic lung injury [10]. These results suggest that TLR4
may exert diverse effects on fibrosis, which depend on the
types of target tissues and stimulating ligands. In our study,
the TLR4 expression pattern appeared to be similar to TLR2
in human chronic IIP, but decreased expression was
observed in UIP, particularly, in the fibrotic areas. Although
the etiology or initiating stimuli in human chronic IIP are
unknown, our observation raises the possibility that TLR4
may act as a regulator of pulmonary fibrosis in human
chronic IIP.
Nevertheless, the present study, based on immunohis-
tochemistry in excised tissues, could not provide robust
evidences for the functional roles of the TLR2 and TLR4
expressed by RE cells in human chronic IIP or IPF. Although
TLR2 and TLR4 expressed by normal human RE cells werefound to be functional in previous in vitro studies
[16,18,19], further studies are warranted to more clearly
address the roles of TLR2 and TLR4 on RE cells in human
chronic IIP.
In conclusion, this study demonstrates that TLR2 and
TLR4 expression is increased in the RE cells of human UIP
and NSIP tissues and therefore may be involved in the
pathogenesis of human chronic IIP. The expression pattern
of TLR2 in RE cells supports a pro-fibrotic role of TLR2 in
human UIP and IPF as suggested by previous experiments
using a mouse model.
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